The TRANSVAC consortium was originally established by 13 European partners of complementary expertise in the field of vaccine development. Each participating institution is providing a spectrum of coordinated vaccine development facilities. However, the long-term vision of TRANSVAC is to establish an efficient sustainable collaborative infrastructure based on shared visions and goals. Therefore, in 2012, TRANSVAC will launch a special call inviting applications for external institutions to join and further complement and strengthen the consortium, should they be able to bring relevant resources and experience for mutual benefit.

Information on the call will be published on this website in due course.